- Report
- July 2026
- 152 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- November 2025
- 160 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- March 2026
- 113 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- January 2026
- 107 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- May 2026
- 400 Pages
Global
From €4577EUR$4,949USD£3,820GBP
- Report
- May 2026
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- May 2026
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- February 2026
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- February 2026
- 208 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- February 2026
- 178 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- February 2026
- 191 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- February 2026
- 190 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- December 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- December 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- November 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- November 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- November 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- September 2026
- 291 Pages
Europe
From €4439EUR$4,799USD£3,704GBP
- Report
- September 2026
- 293 Pages
North America
From €4439EUR$4,799USD£3,704GBP
- Report
- July 2026
- 75 Pages
Asia Pacific
From €4393EUR$4,750USD£3,666GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more